A detailed history of Cmh Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cmh Wealth Management LLC holds 2,254 shares of ABBV stock, worth $408,289. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,254
Previous 2,254 -0.0%
Holding current value
$408,289
Previous $386,000 15.28%
% of portfolio
0.11%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$154.79 - $180.76 $348,896 - $407,433
2,254 New
2,254 $386,000
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $1.9 Million - $2.54 Million
-25,838 Closed
0 $0
Q1 2020

Apr 16, 2020

BUY
$64.5 - $97.79 $404,544 - $613,338
6,272 Added 32.06%
25,838 $1.97 Million
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $159,046 - $199,001
2,205 Added 12.7%
19,566 $1.73 Million
Q3 2019

Oct 11, 2019

SELL
$62.98 - $75.72 $137,989 - $165,902
-2,191 Reduced 11.21%
17,361 $1.32 Million
Q2 2019

Jul 15, 2019

BUY
$65.7 - $83.98 $3,022 - $3,863
46 Added 0.24%
19,552 $1.42 Million
Q1 2019

Apr 15, 2019

SELL
$77.14 - $90.79 $1.09 Million - $1.28 Million
-14,095 Reduced 41.95%
19,506 $1.57 Million
Q4 2018

Jan 16, 2019

BUY
$77.85 - $96.01 $70,065 - $86,409
900 Added 2.75%
33,601 $3.1 Million
Q3 2018

Oct 29, 2018

BUY
$88.91 - $98.84 $239,612 - $266,373
2,695 Added 8.98%
32,701 $3.11 Million
Q2 2018

Jul 20, 2018

BUY
$89.78 - $106.23 $381,205 - $451,052
4,246 Added 16.48%
30,006 $2.79 Million
Q1 2018

Apr 11, 2018

BUY
$92.01 - $123.21 $6,900 - $9,240
75 Added 0.29%
25,760 $2.36 Million
Q4 2017

Jan 12, 2018

BUY
$89.56 - $98.21 $2,686 - $2,946
30 Added 0.12%
25,685 $2.53 Million
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $1.79 Million - $2.29 Million
25,655
25,655 $2.32 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cmh Wealth Management LLC Portfolio

Follow Cmh Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cmh Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cmh Wealth Management LLC with notifications on news.